Affinity Asset Advisors’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-750,000	Closed	-$7.5M	–	64
2021 Q3	$7.5M	Buy	750,000 +500,000	+200%	+$5M	1.89%	8
2021 Q2	$3.55M	Buy	250,000 +22,500	+10%	+$319K	1.27%	16
2021 Q1	$3.73M	Buy	227,500 +7,500	+3%	+$123K	1.27%	15
2020 Q4	$4.55M	Buy	+220,000	New	+$4.55M	2.41%	8